Diabetes

Insulin glargine-aglr received initial FDA approval in December 2021.

Drs Meece and Goldman share final thoughts on the overall current and future treatment landscape for diabetes.

Addressing fears surrounding insulin injections through education may positively impact treatment adherence.

Experts provide suggestions for optimizing patient education by encouraging patient engagement.

Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, discusses topics to address with patients to ensure appropriate self-administration of insulin.

According to a study, use is linked to a lower prevalence of age-related macular degeneration in European populations.

Dr Meece navigates insulin therapy education and ensuring patient adherence.

Drs Goldman and Meece discuss factors surrounding insulin administration.

Drs Goldman and Meece explore an array of drug therapies available to treat diabetes.

Omnipod DASH PDMs are at increased risk of malfunction if overcharged beyond the maximum battery voltage.

Many diabetes patients are rationing supplies, putting off purchasing them, or completely forgoing them because of costs.

To commemorate Diabetes Awareness Month, the pharmacy is offering a variety of free services.

Patients can face risks like hypertension and difficult delivery.

Key opinion leaders share strategies to effectively educate patients on diabetes.

Drs Jerry Meece and Jennifer Goldman offer treatment plans based on individualized patient care models for patients with diabetes.

Pharmacy experts share insights on the impact of assistance programs offered for patients with diabetes.

Research shows that an increase in intermittent scanning helps improve glycemic control and reduce the fear of hypoglycemia.

Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, explores strategies to increase patient adherence to treatment.

Jerry Meece, RPh, CDCES, FACA, FADCES, initiates a discussion around the increasing prevalence of patients diagnosed with diabetes.

Study examines patient action that ‘is frequently harmful, and sometimes deadly'.

An analysis of data from more than 640,000 people with diabetes recorded between 2015-2020 is providing new insight into what study investigators are calling "troubling" trends in the incidence of CKD in the face a growing diabetes epidemic.

Examining the benefits of using flash glucose monitoring in patients with type 1 diabetes.

Patients with metabolic syndrome and diabetes may be experiencing challenges outside medication management.

New data indicate that a diabetes diagnosis may be associated with earlier onset of menopause.

Pre-pandemic survey examines effects of heart disease, asthma, and more.